Search results for "Combination"

showing 10 items of 1379 documents

Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease

1993

Abstract Background: The role of azathioprine (AZA) in the treatment of active Crohn's disease (CD) is still controversial. This study examined whether AZA combined with standard prednisolone therapy improved the therapeutic outcome compared with monotherapy with prednisolone. Methods: Forty-two patients with a Crohn's Disease Activity Index (CDAI) of > 150 were randomized into two groups. Both received 60 mg of prednisolone daily in a tapering regimen to a maintenance dose of 10 mg. In addition, group 1 received 2.5 mg AZA/kg body wt and group 2 received a placebo over the whole study period of 4 months. Results: At the end of the trial, 16 of 21 patients (76%) in group 1 were in remission…

Adultmedicine.medical_specialtyAdolescentPrednisolonemedicine.medical_treatmentAzathioprinePlaceboGastroenterologylaw.inventionCrohn DiseaseRandomized controlled triallawInternal medicineAzathioprinemedicineHumansChemotherapyHepatologybiologyMaintenance dosebusiness.industryC-reactive proteinGastroenterologyMiddle AgedSurgeryRegimenTreatment OutcomePrednisolonebiology.proteinDrug Therapy Combinationbusinessmedicine.drugGastroenterology
researchProduct

Rituximab in refractory pemphigus vulgaris

2008

Pemphigus vulgaris (PV) is a severe chronic autoimmune blistering disease of skin and mucous membranes. The use of systemic corticosteroids in pemphigus has dramatically reduced its mortality rate, but the long-term use of steroids leads to severe side effects, many of which are serious. For this reason it is often necessary to add immunosuppressive agents to the regimen. However, there are occasional refractory cases in which therapy with conventionally accepted modalities is either not efficacious or not possible on account of side effects. Rituximab is a therapeutic monoclonal antibody targeting CD20, an integral membrane protein highly expressed on the surface of pre-B lymphocytes and a…

Adultmedicine.medical_specialtyAntigens CD19B-Lymphocyte SubsetsDrug ResistanceDermatologyDrug Administration ScheduleAntibodies Monoclonal Murine-DerivedPharmacotherapyRefractoryRituximab pemphigus vulgarisimmune system diseasesHumansImmunologic FactorsMedicineInfusions IntravenousCD20integumentary systembiologybusiness.industryRemission InductionPemphigus vulgarisAntibodies MonoclonalGeneral MedicineAntigens CD20medicine.diseaseDermatologyRegimenPemphigusMonoclonalImmunologybiology.proteinPrednisoneDrug Therapy CombinationFemaleRituximabRituximabbusinessImmunosuppressive AgentsPemphigusmedicine.drugDermatologic Therapy
researchProduct

Double Endocrine Neoplasia in a Renal Transplant Recipient: Case Report and Review of the Literature

2011

Abstract Introduction The incidence of cancer compared for age groups is 3–4 times higher in transplant recipients than the general population. The increased risk is related to immunosuppressive therapy as well as the use of increasingly older donors and recipients. Although cardiovascular disease with a functioning transplant is the leading cause of death (47%), cancer mortality is significant especially among older patients. However, the most frequent posttransplantation cancers relate to hemolymphopoietic organs and skin, whereas the occurrence of solid tumors elsewhere is rare. Herein we have described a rare case of synchronous double malignancy of endocrine organs (thyroid-adrenal) in…

Adultmedicine.medical_specialtyBiopsymedicine.medical_treatmentAdrenal neoplasmSettore MED/08 - Anatomia PatologicaNephrectomyEndocrine neoplasia renal transplant recipientAdrenocortical CarcinomamedicineAdjuvant therapyHumansAdrenocortical carcinomaThyroid NeoplasmsMultiple endocrine neoplasiaThyroid cancerNeoplasm StagingTransplantationOxyphil Cellsbusiness.industryCarcinomaGraft SurvivalMultiple Endocrine NeoplasiaThyroidectomyAdrenalectomyMycophenolic Acidmedicine.diseaseKidney TransplantationAdrenal Cortex NeoplasmsCarcinoma PapillaryNephrectomySurgeryTransplantationSettore MED/18 - Chirurgia GeneraleTreatment OutcomeThyroid Cancer PapillaryCyclosporineThyroidectomyKidney Failure ChronicLymph Node ExcisionDrug Therapy CombinationFemaleSteroidsSurgeryTomography X-Ray ComputedbusinessImmunosuppressive AgentsTransplantation Proceedings
researchProduct

The Treatment of Mild and Moderate Asthma in Adults

2020

BACKGROUND: Asthma is a chronic inflammatory airway disease that usually causes variable airway obstruction. It affects 5–10% of the German population. METHODS: This review is based on relevant publications retrieved by a selective search, as well as on national and international guidelines on the treatment of mild and moderate asthma in adults. RESULTS: The goal of treatment is to attain optimal asthma control with a minimal risk of exacerbations and mortality, loss of pulmonary function, and drug side effects. This can be achieved with a combination of pharmacotherapy and non-drug treatment including patient education, exercise, smoking cessation, and rehabilitation. Pharmacohterapy is ba…

Adultmedicine.medical_specialtyContinuing Medical EducationModerate asthma03 medical and health sciences0302 clinical medicinePharmacotherapyGerman populationimmune system diseasesAdrenal Cortex HormonesFormoterol FumarateInternal medicineAdministration InhalationmedicineHumansAnti-Asthmatic Agents030212 general & internal medicineAsthmaInhalationbusiness.industryGeneral Medicinerespiratory systemAirway obstructionmedicine.diseaseAsthmarespiratory tract diseasesAirway disease030228 respiratory systemDrug Therapy CombinationFormoterol FumaratebusinessDeutsches Ärzteblatt international
researchProduct

Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.

1991

Hirsutism in women is often explained on the basis of abnormal peripheral androgen metabolism. To determine whether serum markers of ovarian, adrenal, or peripheral androgen production may be helpful determinants in the treatment of hirsutism and to compare the efficacy of treatment with dexamethasone or spironolactone, 20 hyperandrogenic hirsute patients were treated for up to 2 years. Eleven women who were selected on the basis of sensitivity to dexamethasone were treated with a daily dose of 0.37 mg dexamethasone and had androgen levels suppressed into the normal range. Although significant (P less than .05), Ferriman-Gallwey scores decreased only by 20%: 14.2 +/- 0.5 to 11.4 +/- 0.6. Ni…

Adultmedicine.medical_specialtyHirsutismAdolescentmedicine.drug_classmedicine.medical_treatmentSpironolactoneAndrogen suppressionAntiandrogenAndrosteroneDexamethasonechemistry.chemical_compoundInternal medicinemedicineHumansTestosteronehirsutismDexamethasoneChemotherapybusiness.industryDehydroepiandrosterone SulfateAndrostenedioneObstetrics and GynecologyAndrogen AntagonistsDihydrotestosteroneGeneral MedicineDehydroepiandrosteroneAndrogenmedicine.diseaseAndrostane-317-diolDrug CombinationsEndocrinologychemistrySpironolactoneAndrogensCorticosteroidFemalebusinessmedicine.drugObstetrics and gynecology
researchProduct

Is intravesical instillation of hyaluronic acid and chondroitin sulfate useful in preventing recurrent bacterial cystitis? A multicenter case control…

2015

Abstract Objective Urinary tract infections (UTIs) are common in the female population and, over a lifetime, about half of women have at least one episode of UTI requiring antibiotic therapy. The aim of the current study was to compare two different strategies for preventing recurrent bacterial cystitis: intravesical instillation of hyaluronic acid (HA) plus chondroitin sulfate (CS), and antibiotic prophylaxis with sulfamethoxazole plus trimethoprim. Materials and methods This was a retrospective review of two different cohorts of women affected by recurrent bacterial cystitis. Cases (experimental group) were women who received intravesical instillations of a sterile solution of high concen…

Adultmedicine.medical_specialtyRecurrent bacterial cystitismedicine.drug_classUrinary systemCystitiAntibioticsUrinalysislcsh:Gynecology and obstetricsGastroenterologyantibioticsantibiotics; chondroitin sulfate; cystitis; hyaluronic acidchemistry.chemical_compoundAdjuvants ImmunologicRecurrenceInternal medicineObstetrics and GynaecologyHyaluronic acidCystitismedicineHumansChondroitin sulfateAntibiotic prophylaxisHyaluronic Acidlcsh:RG1-991antibiotics chondroitin sulfate cystitis hyaluronic acidchondroitin sulfateRetrospective StudiesDose-Response Relationship Drugbusiness.industrySulfamethoxazoleChondroitin SulfatesAntibioticObstetrics and GynecologySettore MED/40 - Ginecologia E OstetriciaTrimethoprimSurgeryAdministration IntravesicalInstillation DrugchemistryUrinary Tract InfectionsDrug Therapy CombinationFemalebusinessmedicine.drugFollow-Up StudiesTaiwanese journal of obstetricsgynecology
researchProduct

How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?

2007

Despite their young age, women with polycystic ovary syndrome (PCOS) have increased cardiovascular risk. Besides normal concentrations of low-density lipoprotein (LDL) cholesterol, dyslipidemia is very common and includes elevated triglyceride levels and low high-density lipoprotein cholesterol concentrations. Recent findings also showed that women with PCOS have qualitative LDL alterations, with increased levels of atherogenic small, dense LDL particles. Such lipid abnormalities constitute a common form of dyslipidemia, the so-called atherogenic lipoprotein phenotype (ALP), associated with a greater cardiovascular risk. Weight reduction and increased physical activity may constitute first-…

Adultmedicine.medical_specialtySettore MED/09 - Medicina Interna10265 Clinic for Endocrinology and Diabetology610 Medicine & healthRisk AssessmentSeverity of Illness IndexSettore MED/13 - Endocrinologiachemistry.chemical_compoundWeight lossInternal medicinemedicineHumansatherosclerosis high-density lipoprotein cholesterol polycystic ovary syndrome small and dense low-density lipoprotein triglyceridesDyslipidemiasTriglyceridebusiness.industryCholesterolCholesterol HDLnutritional and metabolic diseasesObstetrics and Gynecology2729 Obstetrics and GynecologyCholesterol LDLmedicine.diseaseAtherosclerosisPrognosisPolycystic ovaryMetforminEndocrinologyTreatment OutcomechemistryCardiovascular Diseaseslipids (amino acids peptides and proteins)Drug Therapy CombinationFemaleControlled Clinical Trials as Topicmedicine.symptomHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessPioglitazoneDyslipidemiamedicine.drugLipoproteinPolycystic Ovary Syndrome
researchProduct

Abscess of the orbit arising 48 h after root canal treatment of a maxillary first molar

2006

Aim  To discuss a rare, but severe complication arising following routine root canal treatment. Summary  An orbital abscess is reported that occurred following routine root canal treatment. A young, healthy female patient, with no history of chronic paranasal infection had undergone root canal treatment of the right maxillary first molar. On hospital admission, she presented with extensive periorbital swelling and discreet diplopia. Computed tomography imaging identified massive purulent sinusitis and subsequent involvement of the orbit via the inferior and medial orbital wall within 48 h after completion of root canal treatment. Immediate surgical drainage of the maxillary sinus and the or…

Adultmedicine.medical_specialtygenetic structuresMaxillary sinusRoot canalAmoxicillin-Potassium Clavulanate CombinationMetronidazoleMaxillaOrbital DiseasesmedicineMaxillary first molarHumansSinusitisAbscessGeneral DentistryOdontogenic infectionPeriapical periodontitisbusiness.industryMaxillary Sinusitismedicine.diseaseMolarAbscesseye diseasesAnti-Bacterial AgentsRoot Canal TherapySurgeryDrug Combinationsmedicine.anatomical_structureDrainageFemalesense organsGentamicinsTomography X-Ray ComputedbusinessPeriapical PeriodontitisOrbit (anatomy)International Endodontic Journal
researchProduct

Combined therapy with acyclovir and adenosine arabinoside in herpes simplex encephalitis.

1987

We report a case of herpes simplex encephalitis (HSE) with initial coma and severe left-sided hemiparesis in which combined treatment with adenine arabinoside and acyclovir was followed by complete recovery. This favorable result is discussed in view of the literature of HSE treatment including experimental studies on antiviral activity of both drugs. Combined treatment may be useful in severe cases of HSE.

Adultmedicine.medical_treatmentAcyclovirmedicineHumansAciclovirVidarabineComaChemotherapybusiness.industryHerpes Simplexmedicine.diseaseVirologyAdenosineHemiparesisNeurologyEncephalitisDrug Therapy CombinationFemaleNeurology (clinical)Viral diseasemedicine.symptombusinessTomography X-Ray ComputedEncephalitisVidarabinemedicine.drugEuropean neurology
researchProduct

Principles and requirements for stroke recovery science

2020

The disappointing results in bench-to-bedside translation of neuroprotective strategies caused a certain shift in stroke research towards enhancing the endogenous recovery potential of the brain. One reason for this focus on recovery is the much wider time window for therapeutic interventions which is open for at least several months. Since recently two large clinical studies using d-amphetamine or fluoxetine, respectively, to enhance post-stroke neurological outcome failed again it is a good time for a critical reflection on principles and requirements for stroke recovery science. In principal, stroke recovery science deals with all events from the molecular up to the functional and behav…

Agingmedicine.medical_specialtyCombination therapymedicine.medical_treatmenttranslationNeuroprotectioncombination therapyrecovery03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationchronic strokeHumansMedicineReview ArticlesChronic strokeStroke030304 developmental biologyNeurotransmitter Agents0303 health sciencesbusiness.industryRegeneration (biology)BrainRecovery of Functionmedicine.diseaseStrokeMatrix Metalloproteinase 9NeurologyTissue Plasminogen ActivatorregenerationIntercellular Signaling Peptides and ProteinsNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessStroke recovery030217 neurology & neurosurgeryJournal of Cerebral Blood Flow & Metabolism
researchProduct